labs for glp 1 GLP-1 Therapy Northline Labs | Premium Research
Description
Screening for inflammatory markers identifies IL-18R as a potential link between Exenatide and its anti-inflammatory effect: new results from the combat-JUDO randomized controlled trial
As illustrated in Figure 2, pooled analyses of cardiovascular outcome trials have demonstrated that GLP-1 RAs reduce major adverse cardiovascular events (MACEs) by 14% (HR = 0.86, 95% CI 0.790.94) in patients with type 2 diabetes, with additional significant benefits including 13% reduction in cardiovascular death, 16% reduction in nonfatal stroke, and 10% reduction in hospitalization for heart failure [85]
ChenJCZhaoHCMaXLZhangYCLuSMWangYGet al
What matters is that its liquid and that the label lists 5% acidity
orals may expand the addressable base (daily pill = new adherence trade-offs), but the near-term remains pen-driven
